Activated and expanded natural killer cells target osteosarcoma tumor initiating cells in an NKG2D-NKG2DL dependent
L Fernández1, J Valentín2, M Zalacain3
1Clinical Research Department, Spanish National Cancer Research Centre CNIO, C/Melchor Fernández Almagro, 3, 28029 Madrid, Spain.
Abstract:
Current therapies fail to cure most metastatic or recurrent bone cancer. We explored the efficacy and the pathways involved in natural killer (NK) cells' elimination of osteosarcoma (OS) cells, including tumor initiating cells (TICs), which are responsible for chemotherapy resistance, recurrence, and metastasis. The expression of ligands for NK cell receptors was studied in primary OS cell lines by flow cytometry. In vitro cytotoxicity of activated and expanded NK (NKAE) cells against OS was tested, and the pathways involved explored by using specific antibody blockade. NKAE cells' ability to target OS TICs was analyzed by flow cytometry and sphere formation assays. Spironolactone (SPIR) was tested for its ability to increase OS cells' susceptibility to NK cell lysis in vitro and in vivo. We found OS cells were susceptible to NKAE cells' lysis both in vivo and in vitro, and this cytolytic activity relied on interaction between NKG2D receptor and NKG2D ligands (NKG2DL). SPIR increased OS cells' susceptibility to lysis by NKAE cells, and could shrink the OS TICs. Our results show NKAE cells target OS cells including the TICs compartment, supporting the use of NK-cell based immunotherapies for OS.
Insights
Natural killer (NK) cells effectively eliminate osteosarcoma (OS) cells, including treatment-resistant tumor-initiating cells (TICs). Spironolactone enhances NK cell therapy efficacy against bone cancer.
Area of Science:
- Immunology
- Oncology
- Cell Biology
Background:
- Metastatic and recurrent bone cancer, particularly osteosarcoma (OS), remains difficult to treat with current therapies.
- Tumor-initiating cells (TICs) drive chemotherapy resistance, recurrence, and metastasis in OS.
- Natural killer (NK) cells are crucial for innate immunity and possess anti-tumor properties.
Purpose of the Study:
- To investigate the efficacy of activated and expanded NK (NKAE) cells in eliminating osteosarcoma (OS) cells and OS tumor-initiating cells (TICs).
- To elucidate the molecular pathways involved in NK cell-mediated OS cell lysis.
- To evaluate the potential of spironolactone (SPIR) in enhancing NK cell therapy for OS.
Main Methods:
- Flow cytometry to assess NK cell receptor ligand expression on OS cells and NKAE cell targeting of OS TICs.
- In vitro cytotoxicity assays of NKAE cells against OS cells.
- Antibody blockade to explore NK cell-mediated lysis pathways.
- Sphere formation assays to analyze NKAE cell targeting of OS TICs.
- In vitro and in vivo studies of spironolactone's effect on OS cell susceptibility to NK cell lysis.
Main Results:
- Osteosarcoma cells are susceptible to lysis by NKAE cells both in vitro and in vivo.
- NKAE cell-mediated cytotoxicity relies on the interaction between the NKG2D receptor and NKG2D ligands (NKGKL).
- Spironolactone enhances OS cell susceptibility to NKAE cell lysis and reduces OS TICs.
- NKAE cells effectively target the OS TICs compartment.
Conclusions:
- NKAE cells demonstrate significant potential in targeting and eliminating osteosarcoma cells, including TICs.
- The NKG2D/NKG2DL pathway is critical for NK cell-mediated osteosarcoma cell killing.
- Spironolactone can augment NK-cell based immunotherapy by increasing cancer cell susceptibility to NK cell-mediated lysis, offering a promising therapeutic strategy for osteosarcoma.
More Related Videos
Related Concept Videos
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Targeted Cancer Therapies
There are several types of targeted therapies against...


